Biorestorative Therapies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.31

-0.24 (-9.41%)

As of Sep 28, 10:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,032.9% upside

Low Target $18.72

Average Target $26.17

High Target $39.89

Current Price $2.31

Current
$2.31

Target
$26.17

$18.72 $26.17 avg $39.89

Scenario Analysis

Bear Case

$18.72

710.4%

Low target

Base Case

$26.17

+1,032.9%

Avg target

Bull Case

$39.89

+1,626.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$34.60

-93.3% from high

52-Week Low

$2.50

+-7.6% from low

Target vs 52W High

$26.17

-24.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%